SCHEMBL6537320

SCHEMBL6537320

O=C(Nc1cccc2cc(CBr)cnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.47
MAPT P10636 3/20 0.45
PLEC Q15149 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
JAK2 O60674 2/20 0.44
TYK2 P29597 2/20 0.44
JAK1 P23458 1/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 2/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537950 0.89 KDR (0.48) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537481 0.87 MAPT (0.46) KDRMAPTPLECMEN1KMT2A
SCHEMBL6538050 0.86 KDR (0.46) KDRMAPTPLECMEN1KMT2A
SCHEMBL6538309 0.85 PTGES (0.48) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537536 0.84 KDR (0.52) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537616 0.83 KDR (0.46) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537645 0.83 KDR (0.43) KDRMAPTPLECMEN1KMT2A
SCHEMBL8471791 0.82 MAOB (0.47) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537852 0.82 KDR (0.48) KDRMAPTPLECMEN1KMT2A
SCHEMBL6537382 0.81 SLC40A1 (0.52) KDRMAPTPLECMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed